The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups…
- Investigator
- Angela Pham
- Ages
- 18 Years - 75 Years
- Sexes
- All